Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Chemotherapy. Radiation. MD Anderson Cancer Center, Houston, TX, United States

Survival: 16.6 months
Toxicity Grade: 5
Treatments: Chemotherapy
Country: United States
City/State/Province: Houston, TX
Hospital: MD Anderson Cancer Center
Journal: Link
Date: 11/2013

This phase 3 study involved newly diagnosed glioblastoma patients who were divided into two separate treatment groups. Group A had 411 patients of whom 27% were younger than 50 years and 58% were male. Group B had 422 patients of whom 26% were younger than 50 years and 56% were male.

Patients in group A were given radiation therapy and chemotherapy with the standard dose of temozolomide.

Group B was treated with radiotherapy and a dose-dense temozolomide regimen.

An unspecified number of treatment-related deaths were reported for group A. Grade 4 lymphopenia and grade 3 fatigue were also reported.

An unspecified number of treatment-related deaths were reported for group B. Grade 4 thrombocytopenia and lymphopenia were also reported.

The median overall survival times for groups A and B were 16.6 and 14.9 months, respectively.

Several of the study’s authors have received some form of funding from pharmaceutical companies such as Merck and Genentech.

Correspondence: Dr. Mark R. Gilbert; email:

E-mail to a Friend Email Physician More Information